Gene control company Concinnity Genetics, recently spun out of the University of Edinburgh, has raised £3 million in an oversubscribed seed funding round that included Old College Capital (OCC) - the University of Edinburgh’s in-house venture investment fund.
Biotechnology spinout Kynos Therapeutics has been acquired by clinical stage biopharmaceutical company Dr. Falk Pharma GmbH, which will develop Kynos’ KMO inflammation inhibitors for the treatment of acute pancreatitis.
Biotech spinout Resolution Therapeutics has announced it has raised £63.5 million in a series B financing round led by healthcare investor Syncona Ltd.
A company that grows nutrient-rich algae from whisky waste to help preserve wild fish populations has been announced as a finalist for the prestigious Earthshot Prize 2024.
Student startup MiAlgae, which uses co-products from the whisky industry to sustainably produce Omega-3 for fish feed, has secured £14 million in funding to build an industrial scale production facility in Scotland.
Waste textiles from sailing boats could be given a new lease of life thanks to a research project to turn plastic fibres from sails into chemicals such as vanillin – the compound used in cosmetics and food products for a vanilla flavour and smell.
What’s your next challenge? Spin in, spin out or start up?
